|
JP2008291017A
|
|
Wip1 EXPRESSION-POTENTIATING AGENT AND CANCER TREATMENT SENSITIZER
|
|
JP2007153777A
|
|
Composition having urinary tract symptom-ameliorating effect
|
|
JP2003171289A
|
|
Analgesic pharmaceutical composition
|
|
JP2002332274A
|
|
Method for manufacturing squalamine
|
|
JP2002241298A
|
|
Composition effective for reducing blood glucose
|
|
JPH11158077A
|
|
Composition having alleviating effect on stress
|
|
JPH10236966A
|
|
Composition having blood circulation-ameliorating effect
|
|
JPH09169659A
|
|
Composition having antinuclear antibody decreasing action and rheumatoid factor decreasing action
|
|
JPH06107553A
|
|
Composition having analgesic function
|
|
JPH0597691A
|
|
Composition having action to remit ophthalmic disease and to maintain ophthalmic function
|
|
JPH0597690A
|
|
Composition having action to maintain ophthalmic function and to remit ophthalmic disease
|
|
JPH01290613A
|
|
Remedy for dermatosis and cosmetic
|
|
JPS61148118A
|
|
Carcinostatic agent
|
|
JPS61148119A
|
|
Carcinostatic agent
|
|
JPS6133121A
|
|
Carcinostatic
|
